Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health, through the Department of Health and Human Services, is issuing a forecast for a limited competition grant to support Mature Synchrotron Resources for Structural Biology. This program is designed to maintain state-of-the-art X-ray beamlines at synchrotron facilities, ensuring biomedical researchers have access to expert assistance, hands-on training, and the necessary tools to analyze structural biology data. Eligible organizations are invited to apply for this P30 grant, though clinical trials are not allowed. Applications will undergo a standard NIH peer-review process, and funding will be awarded only to those deemed meritorious. Interested parties can contact the MSR P30 mailbox for further information regarding this opportunity.

General Info

Funding supports advanced synchrotron facilities for structural biology research and user training.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedDec 8

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health

Office AddressUSA

Contacts

MSR P

contact@example.gov

Full Description

Show more

The NIGMS Mature Synchrotron Resources for Structural Biology program supports mature technologies at synchrotron facilities that provide biomedical researchers with state-of-the-art X-ray beamlines, hands-on user training, and expert assistance to generate and analyze structural biology data. NIGMS intends to reissue a Notice of Funding Opportunity to continue to support these important national resources.

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.

Similar Contracts

Same NAICS industry code

Satellite Imagery & Elevation Product SupplyThis subcontract agreement involves the supply of raw and processed satellite imagery and elevation products to support prime contractors on Geomatics Yukon projects for the Government of Yukon. The scope of work focuses on providing comprehensive geographic coverage of the Yukon region through the use of satellite constellations and remote sensing data, specifically delivering Digital Elevation Models and Digital Terrain Models. The contractor is responsible for providing downloadable imagery files and elevation data products via a Call-Up system, ensuring all deliverables include the necessary licensing and permitted-use rights. This procurement falls under NAICS code 541715, with a response deadline set for November 2, 2026.

Government of Yukon

POSTED

about 14 hours ago

DEADLINE

Advanced Manufacturing & Robotics SystemsThis subcontract under the Department of Defense focuses on the supply and integration of advanced manufacturing technologies for prime contractors supporting Army Contracting Command Red River Army Depot projects. The scope of work involves the implementation of hybrid manufacturing cells, advanced robotics, and agile manufacturing kits designed for point-of-need applications. The technical requirements emphasize the integration of Human-Machine Interfaces and the application of artificial intelligence and machine learning to enable predictive maintenance, real-time process monitoring, and optimized scheduling. The final deliverables include fully installed robotics cells and AI-driven monitoring software to enhance operational efficiency.

Department Of Defense

POSTED

DEADLINE

Undersea Robotic and Autonomous Systems (URAS) EngineeringThe Undersea Robotic and Autonomous Systems (URAS) Engineering subcontract supports prime contractors for the Department of Defense, specifically the Naval Undersea Warfare Center Division Newport. The scope of work focuses on the development of AI-enabled autonomy and robotic platforms designed for all ocean depths, including the engineering of autonomous undersea vehicles, seabed warfare systems, and robotic presence capabilities. The primary objective of this engagement is the delivery of functional autonomous undersea prototypes and associated software. Performance for this contract is centered in Newport, Massachusetts, under NAICS code 541715, ensuring advanced technological capabilities for naval undersea warfare operations.

Nuwc Division Newport

POSTED

DEADLINE

Undersea Sensing & Acoustic Systems DevelopmentThe Undersea Sensing and Acoustic Systems Development subcontract supports the Department of Defense and the Naval Undersea Warfare Center Division Newport. The primary objective is the development and supply of undersea sensors, hydrophones, and transducers for prime contractors. This effort focuses on acoustic sensor miniaturization and the creation of novel transducers designed to improve the performance of Naval Anti-Submarine Warfare platforms. The scope of work includes the delivery of advanced acoustic sensing hardware and detailed research and development reports. Performance for this contract is centered in Newport, Massachusetts, under NAICS code 541715. The project emphasizes technical innovation in sensing capabilities to enhance overall naval operational effectiveness.

Nuwc Division Newport

POSTED

DEADLINE

Broad Agency Announcement (BAA): Cost Estimating Modeling Data, Analytics Research (CEMDAR)

Solicitation # FA701426SCS02

The Secretary of the Air Force Financial Management (SAF/FM) is soliciting white papers for the Cost Estimating Modeling Data Analytics Research (CEMDAR) initiative. This 100% Small Business Set-Aside under NAICS 541715 has an estimated program ceiling of 24 million dollars for a single award with a period of performance ranging from 12 to 60 months. The program aims to modernize Department of the Air Force cost estimating capabilities by transitioning from legacy desktop tools to secure enterprise cloud platforms, implementing relational data architectures, automating data pipelines, and advancing scalable predictive modeling. The research is organized into five core competencies covering enterprise data governance, automated pipeline engineering using a medallion architecture, data-driven predictive modeling, modernization of the AFCAA Contracts Database, and mission augmentation surge capabilities. This is a two-step acquisition process where only white papers are currently being solicited, with a submission deadline of October 19, 2026. A mandatory evaluation gate requires the prime contractor to possess an active Top Secret Facility Clearance at the time of submission. White papers are limited to 30 pages and must include administrative metadata, a technical approach aligned with the core competencies, a comprehensive Rough Order of Magnitude cost estimate, and identified associate contractor agreements. Successful respondents will be invited to submit formal technical and cost proposals. The government intends to utilize cost-reimbursement contracts and requires that all key personnel hold at least a Secret security clearance at the time of award.

POSTED

DEADLINE

Missile Defense Agency - Advanced Capability Concepts

Solicitation # HQ0860-25-S-C001

The Missile Defense Agency (MDA) has issued solicitation HQ0860-25-S-C001 for Advanced Capability Concepts, an ongoing opportunity open from May 9, 2025, to May 8, 2030. The agency is seeking innovative concepts, technological breakthroughs, and prototype demonstrations to enhance the robustness of all Missile Defense System elements. Key areas of interest include kinetic and hypersonic defense, command and control battle management utilizing AI and quantum computing, integrated non-kinetic and electronic warfare, disruptive technologies, space-based sensors, and the digital revolution. The solicitation is issued under the MDA Multiple Authority Announcement and allows for various contract vehicles, including FAR-based procurement, Other Transaction (OT) agreements, BAA, PEP, and CSO. The procurement follows a two-step process beginning with the submission of a white paper. Submissions must include a title page with a 250-word abstract, a 10-page combined executive summary and program description, a milestone chart, a description of prior work, a Rough Order of Magnitude cost estimate, and a program summary quad chart. Evaluation is based on technical merit, importance to agency programs, and funding availability, with specific weighting placed on technical achievement, research capabilities, and program management. Offerors must be registered in the System for Award Management (SAM) and are required to disclose any organizational conflicts of interest. While there is no predefined budget, the MDA will consider all contract types recommended by the offeror.

Missile Defense Agency (mda)

POSTED

DEADLINE

in over 3 years

AI and Data Science Specialist Support – Health and Extreme Weather Project

Solicitation # 27-000165

The National Institutes of Health Clinical Center intends to procure specialized AI and Data Science Specialist support for the Health and Extreme Weather Intramural study. This two-year project focuses on how extreme heat impacts hospital overcrowding and mortality, specifically utilizing large language models and machine learning to extract critical patient data from unstructured Emergency Medical Services narratives. The scope of work includes technical consultation, AI prototyping, the development of scalable machine-learning pipelines, and the preparation of technical manuscripts and reports. The government intends to award this contract to the University of Maryland, College Park, Department of Electrical and Computer Engineering, citing their Ph.D.-level expertise and existing collaborative relationship with the NIH. The period of performance is divided into two one-year terms starting October 15, 2026. While the government has a preferred source, other responsible parties may submit capability statements by October 8, 2026, to demonstrate their technical qualifications in healthcare-related AI and large-scale data analysis.

National Institutes Of Health Olao

POSTED

DEADLINE

Restorative and health-Enhancing Sleep Time (REST)

Solicitation # ARPA-H-SOL-26-159

The Restorative and health-Enhancing Sleep Time (REST) program, solicitation ARPA-H-SOL-26-159, is an initiative by the Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office to transform the measurement and treatment of poor sleep, specifically insomnia. The program seeks to develop objective, home-based, closed-loop technologies capable of detecting health-relevant sleep microstructures and responding to them in real time. The scope is divided into two technical areas: Technical Area 1 (Measure & Diagnose), focusing on validated in-home systems for objective physiological measurement and mechanistic classification, and Technical Area 2 (Control & Treat), focusing on noninvasive closed-loop systems that adapt interventions to a user's physiology. The ultimate clinical goals are to increase insomnia treatment response from 50% to at least 90% and increase remission from 30% to at least 80%. This 66-month program is structured into three phases: proving the core technical thesis (months 1-24), demonstrating proof-of-concept (months 25-42), and clinical translation and commercialization preparation (months 43-66). Awards will be issued as Other Transactions (OT) and are subject to a quarterly milestone payment schedule. The selection process involves a multi-stage evaluation of Solution Summaries, Full Proposals, and oral Pitches, with awards granted to those determined to be most advantageous to the government based on scientific merit, feasibility, innovation, and proposer capabilities. Key requirements for performers include securing Institutional Review Board (IRB) approval for human subjects research, implementing rigorous safety monitoring for overnight home use, and providing comprehensive FDA regulatory and intellectual property strategies. The final response deadline for proposals is October 13, 2026.

Advanced Research Projects Agency For Health (arpa-H)

POSTED

DEADLINE

Information Processing Techniques Office Office-Wide

Solicitation # HR001126S0011

The Defense Advanced Research Projects Agency Information Processing Techniques Office issued Broad Agency Announcement HR001126S0011 to solicit revolutionary research ideas that provide decisive computational advantages for national security. The scope focuses on three primary thrust areas: AI Innovation and Execution for energy-efficient and trustworthy systems at the network edge, Inherent Security and Privacy to create adaptable and secure cyberspace tools, and Resilient Megasystems to model and protect complex interconnected systems like power grids. This open solicitation is available to all responsible sources, including U.S. and non-U.S. organizations, and may result in awards through procurement contracts, grants, cooperative agreements, or Other Transaction agreements. Submissions follow a two-step evaluation process beginning with a mandatory technical conformance review of a five-page abstract, followed by a comprehensive evaluation for invited proposers. Key evaluation criteria include overall scientific and technical merit, potential contribution to the DARPA mission, plans for implementing resilient software using formal methods, and cost realism. Proposers must possess an active SAM.gov Unique Entity Identifier and meet CMMC Level 2 self-assessment requirements for protecting Controlled Unclassified Information. Due to the nature of the research, strict protocols are in place for classified submissions, and DARPA will conduct risk-based security reviews of all senior key personnel to identify potential foreign influence.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

BAA DEVCOM AC Emerging Technologies

Solicitation # W15QKN-26-S-1AZR

The U.S. Army Combat Capabilities Development Command Armaments Center is soliciting research proposals and white papers through Broad Agency Announcement W15QKN-26-S-1AZR to advance the state of the art in emerging weapons, munitions systems, and soldier lethality technologies. This continuously open solicitation, effective from March 5, 2026, through March 4, 2031, seeks innovative ideas for current and future generation armaments, ammunition, and fire control systems. Key priority areas include lethality support for combat vehicles such as the Abrams, Stryker, XM30, Bradley, and LAV, as well as research into novel power systems, energy harvesting, and model-centric design environments. The Army is also interested in advancements in armament packaging to improve sustainability and usability, as well as micro-system architecture for remote systems. The selection process is conducted under full and open competition, with awards based on scientific merit and military relevance rather than a direct comparison between proposals. Prospective offerors are encouraged to first submit a white paper of no more than five pages, which will be evaluated to determine if a full proposal is warranted. Successful proposals may result in contract awards for periods up to three years, typically structured as one basic year with two one-year options. All submissions must be unclassified and adhere to strict formatting guidelines, including the use of 12-point Times New Roman font. Evaluation factors are listed in descending order of importance, with the final factor being a cost realism analysis compared to available funds.

W6QK Acc-Ri-Picatinny

POSTED

DEADLINE

in over 4 years

T8009-250015 - Zero Emissions Propulsion Systems

Solicitation # WS5207543128

Transport Canada’s Clean Marine program is seeking proposals for research and development to test Zero Emission Propulsion Systems under solicitation WS5207543128, with a contract start date no earlier than June 30, 2026, and all work required to be completed by March 31, 2029. The initiative is focused on advancing marine transportation sustainability through innovation in propulsion technology and is open exclusively to Canadian suppliers as defined by the solicitation’s annex, with offers from non-trading partner countries automatically rejected. The requirement falls under NAICS code 541715 and is governed by the Policy on Reciprocal Procurement, ensuring only domestic entities may bid. Performance will primarily take place in British Columbia, and all submissions must be received by May 25, 2026, at 2:00 PM ET. Point of contact for inquiries is Torrey Buchan of Public Services and Procurement Canada.

Department of Public Works and Government Services

POSTED

DEADLINE

Nuclear Irradiation Testing & Performance QualificationThe Nuclear Irradiation Testing and Performance Qualification subcontract, managed by the Department of Energy Idaho Field Office, involves performing irradiation testing and post-irradiation experimentation for prime contractors on Office of Nuclear Energy projects. The scope of work focuses on testing the response of SiC cladding to irradiation damage and conducting performance qualifications utilizing research reactors and specialized hot cells for the handling of irradiated samples. All activities must strictly adhere to DOE and NRC safety protocols to ensure secure operations. The successful contractor is responsible for delivering comprehensive irradiation performance reports and qualified material data. This opportunity was posted on October 5, 2026, with a response deadline of December 7, 2026, falling under NAICS code 541715.

Idaho Field Office

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.

Book Publishers

POSTED

DEADLINE

Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS